Growing community of inventors

Buntingford, United Kingdom

John Mark Ellard

Average Co-Inventor Count = 5.96

ph-index = 3

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 17

John Mark EllardJeremy Mark Travins (7 patents)John Mark EllardNikolaos Papaioannou (7 patents)John Mark EllardSarah Jocelyn Fink (7 patents)John Mark EllardAlastair Rae (7 patents)John Mark EllardThomas Allen Miller (3 patents)John Mark EllardGerald Wayne Shipps, Jr (3 patents)John Mark EllardDavid Edward Ehmann (3 patents)John Mark EllardJohn Mark Ellard (7 patents)Jeremy Mark TravinsJeremy Mark Travins (52 patents)Nikolaos PapaioannouNikolaos Papaioannou (19 patents)Sarah Jocelyn FinkSarah Jocelyn Fink (9 patents)Alastair RaeAlastair Rae (7 patents)Thomas Allen MillerThomas Allen Miller (54 patents)Gerald Wayne Shipps, JrGerald Wayne Shipps, Jr (33 patents)David Edward EhmannDavid Edward Ehmann (3 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Takeda Pharmaceutical Company Limited (6 from 1,185 patents)

2. Shire Human Genetic Therapies, Inc. (1 from 86 patents)


7 patents:

1. 12441724 - Inhibitors of plasma kallikrein and uses thereof

2. 12221441 - Plasma kallikrein inhibitors and uses thereof

3. 12065448 - Heteroaryl plasma kallikrein inhibitors

4. 11787796 - Plasma Kallikrein inhibitors and uses thereof

5. 11370803 - Heteroaryl plasma kallikrein inhibitors

6. 11352356 - Inhibitors of plasma kallikrein and uses thereof

7. 10730874 - Inhibitors of plasma kallikrein and uses thereof

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/22/2026
Loading…